Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10263362
[patent_doc_number] => 20150148359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/402467
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 29940
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402467
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402467 | Selective inhibitors of undifferentiated cells | May 21, 2013 | Issued |
Array
(
[id] => 10272654
[patent_doc_number] => 20150157651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR USE IN THE TREATMENT OF CLINICALLY ISOLATED SYNDROME AND/OR MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/401934
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12000
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401934
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401934 | TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR USE IN THE TREATMENT OF CLINICALLY ISOLATED SYNDROME AND/OR MULTIPLE SCLEROSIS | May 20, 2013 | Abandoned |
Array
(
[id] => 11921516
[patent_doc_number] => 09789077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Use of saponified tall oil fatty acid'
[patent_app_type] => utility
[patent_app_number] => 14/401259
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 3090
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401259
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401259 | Use of saponified tall oil fatty acid | May 13, 2013 | Issued |
Array
(
[id] => 10373065
[patent_doc_number] => 20150258072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'Antibacterial compositions'
[patent_app_type] => utility
[patent_app_number] => 14/433883
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7076
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433883
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433883 | Antibacterial compositions | May 12, 2013 | Abandoned |
Array
(
[id] => 9422475
[patent_doc_number] => 20140107125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 13/872819
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87037
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872819
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872819 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9263489
[patent_doc_number] => 20130345418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'PROCESS FOR PURIFICATION OF APREPITANT'
[patent_app_type] => utility
[patent_app_number] => 13/872373
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4647
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872373 | PROCESS FOR PURIFICATION OF APREPITANT | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9518874
[patent_doc_number] => 20140155355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'MAO-B INHIBITORS USEFUL FOR TREATING OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/872658
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59188
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872658
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872658 | MAO-B INHIBITORS USEFUL FOR TREATING OBESITY | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9989843
[patent_doc_number] => 09035047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => '7-substituted indole Mcl-1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/868951
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106774
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/868951 | 7-substituted indole Mcl-1 inhibitors | Apr 22, 2013 | Issued |
Array
(
[id] => 10227091
[patent_doc_number] => 20150112084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'PROCESS FOR PREPARATION OF (IS, 3S, 5S)-2-[(2S)-2-AMIN0-2-(3-HYDROXY-l-ADAMANTYL) ACETYL]-2-AZABICYCLO [3.1.0] HEXANE-3-CARBONITRILE'
[patent_app_type] => utility
[patent_app_number] => 14/404686
[patent_app_country] => US
[patent_app_date] => 2013-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5982
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404686
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404686 | Process for preparation of (1S, 3S, 5S)-2-[(2S)-2-amino-2-(3-hydroxy-I-adamantyl) acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile | Apr 21, 2013 | Issued |
Array
(
[id] => 9004732
[patent_doc_number] => 20130225857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'Crosslinked Polymers with the Crosslinker as Therapeutic for Sustained Release'
[patent_app_type] => utility
[patent_app_number] => 13/862500
[patent_app_country] => US
[patent_app_date] => 2013-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6653
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/862500 | Crosslinked polymers with the crosslinker as therapeutic for sustained release | Apr 14, 2013 | Issued |
Array
(
[id] => 10220567
[patent_doc_number] => 20150105560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'FORMULATION COMPRISING IONIC ORGANIC COMPOUNDS FOR USE IN ELECTRON TRANSPORT LAYERS'
[patent_app_type] => utility
[patent_app_number] => 14/399009
[patent_app_country] => US
[patent_app_date] => 2013-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12905
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399009
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399009 | FORMULATION COMPRISING IONIC ORGANIC COMPOUNDS FOR USE IN ELECTRON TRANSPORT LAYERS | Apr 11, 2013 | Abandoned |
Array
(
[id] => 9503624
[patent_doc_number] => 08741939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Modulators of ATP-binding cassette transporters'
[patent_app_type] => utility
[patent_app_number] => 13/848970
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33955
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848970
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848970 | Modulators of ATP-binding cassette transporters | Mar 21, 2013 | Issued |
Array
(
[id] => 10155956
[patent_doc_number] => 09187717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-17
[patent_title] => 'Carboxylate dyes'
[patent_app_type] => utility
[patent_app_number] => 14/384409
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22824
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384409
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384409 | Carboxylate dyes | Mar 18, 2013 | Issued |
Array
(
[id] => 9093656
[patent_doc_number] => 20130272967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Nicotinic Acid and Picolinic Acid Derived Near-Infrared Fluorophores'
[patent_app_type] => utility
[patent_app_number] => 13/828648
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15098
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13828648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/828648 | Nicotinic acid and picolinic acid derived near-infrared fluorophores | Mar 13, 2013 | Issued |
Array
(
[id] => 9608495
[patent_doc_number] => 08785647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Pesticidal arylpyrrolidines'
[patent_app_type] => utility
[patent_app_number] => 13/829353
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163020
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829353
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/829353 | Pesticidal arylpyrrolidines | Mar 13, 2013 | Issued |
Array
(
[id] => 8951190
[patent_doc_number] => 20130196970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'AMINO-PYRROLIDINE-AZETIDINE DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/799616
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35580
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/799616 | Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors | Mar 12, 2013 | Issued |
Array
(
[id] => 10234437
[patent_doc_number] => 20150119431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => '(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel'
[patent_app_type] => utility
[patent_app_number] => 14/400071
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6706
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400071
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400071 | (R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel | Mar 12, 2013 | Issued |
Array
(
[id] => 9055351
[patent_doc_number] => 20130253064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/789259
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 127906
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789259 | Styrenyl derivative compounds for treating ophthalmic diseases and disorders | Mar 6, 2013 | Issued |
Array
(
[id] => 9662340
[patent_doc_number] => 08809316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Use of immunosuppressant compounds in a new indication'
[patent_app_type] => utility
[patent_app_number] => 13/787423
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8506
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13787423
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/787423 | Use of immunosuppressant compounds in a new indication | Mar 5, 2013 | Issued |
Array
(
[id] => 10013874
[patent_doc_number] => 09056884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Process for producing a charge control agent'
[patent_app_type] => utility
[patent_app_number] => 13/785395
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8182
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13785395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/785395 | Process for producing a charge control agent | Mar 4, 2013 | Issued |